|
|
|
|
Lung cancer remains a formidable challenge in healthcare as the leading cause of cancer-related fatalities. To enable comprehensive evaluation of therapies targeting both primary and metastatic tumors, we've developed dual-disease xenograft models using bioluminescence imaging (BLI).
|
|
|
|
|
Pancreatic cancer has a projected incidence of 18.6 per 100,000 by 2050. Review multiple studies utilizing the BxPC-3 human pancreatic cancer model in subcutaneous (SC) NSG and NSG-dKO mouse models, evaluating a range of standard agents, vehicles, and delivery methods.
|
|
|
|
|
In an attempt to unravel the complexities of ovarian cancer, we've put together a study examining the NIH:OVCAR-3 model of the human gynecological malignancy in the subcutaneous setting in NSG mice with multiple standard agents and vehicles.
|
|
|
|
|
Our scientific team provides the necessary support to accelerate the journey of promising ADC candidates from early discovery to clinical development, ultimately enhancing the success rate of translating preclinical discoveries into effective cancer treatments.
|
|
|
|
|
Through close collaboration, proactive communication, and agile project management, see how our partnership was able to accelerate an oncology program and help overcome complex preclinical hurdles with efficiency and precision.
|
|
|
|
|
|
|
